Western Australia – State of Energy
There has always been an energy about Western Australia. It flows through our land, our regions, and our people. This energy powers dynamic industries, fuels innovation and sparks creativity to solve global challenges.
This energy powers our rapidly expanding biomedical industry. Western Australia is fast becoming a global hub for health and medical life sciences with our proximity to the growing Asian market and strong health leadership.
- The sector has more than doubled since 2017, with over 250 biomedical organisations and support services.
- A connected ecosystem of five universities, six tertiary hospitals and 21 medical research institutes and foundations.
- Strong collaboration between government, industry and researchers.
This creates a practical advantage for partners: the ability to move ideas from research to clinical application quickly and efficiently.
Western Australia’s biomedical capabilities
Western Australia offers proven research excellence and growing commercial scale-up capability.
- Two Nobel laureates (Prof. Barry Marshall and Emeritus Prof. Robin Warren)
- Seven FDA-approved drugs developed from Western Australian university research.
- Active pipeline of exciting startups progressing Phase 1, 2 and 3 trials for promising new therapies.
Key strengths include:
- Personalised medicine
- Advanced RNA therapies
- Paediatric health and rare diseases
- Regenerative medicine
- Leading edge clinical trials capabilities (supported by established CDMOs and CROs).
Western Australia also has a strong and growing medtech sector, including:
- precision diagnostics and therapeutics
- remote monitoring digital health products
- specialist manufacturing capabilities
These are underpinned by Western Australia’s expertise in remote and autonomous solutions, translating into innovation and healthcare delivery.
Funding and support
The Western Australian Government is committed to supporting and growing the State’s life sciences sector.
- The Future Health Research and Innovation (FHRI) Fund, valued at around $1.8 billion, provides a secure source of funding to drive health and medical research, innovation and commercialisation.
- Over $340 million already awarded to more than 850 grant recipients since the FHRI Fund was established in 2020.
- Around $350 million available over the next four years to accelerate delivery of the State’s health and medical research and innovation priorities.
This is complemented by:
- the State’s first-ever Health and Medical Life Sciences Industry Strategy launched in October 2021.
- the WA Life Sciences Innovation Hub, a collaboration between the Western Australian Government, MTPConnect and The University of Western Australia, to help accelerate new and growing biotech businesses.
Connect with Western Australia
Western Australia offers a compelling entry point for global companies.
The Western Australian Government’s office in Austin, Texas, provides a one-stop shop for connecting to the Western Australian biomedical sector. Western Australian Investment and Trade Commissioner Brianna Peake and her team will be delighted to facilitate your introduction to our outstanding health and medical innovators and researchers.
Come and say G’day to WA at the Team Australia pavilion and hear more about how Western Australia’s energy is powering biomedical innovation and global partnership opportunities.
For more information
